[1]
M. Debiasi, M. Hehnemann, and B. Garicochea, “Rituximab monotherapy for splenic marginal zone lymphoma with villous lymphocytes: report on long-term disease control for two patients with recurrence after splenectomy”, Sao Paulo Med J, vol. 128, no. 6, pp. 375–377, Nov. 2010.